Surgery – Diagnostic testing – Detecting brain electric signal
Reexamination Certificate
2011-08-23
2011-08-23
Mallari, Patricia C (Department: 3735)
Surgery
Diagnostic testing
Detecting brain electric signal
Reexamination Certificate
active
08005534
ABSTRACT:
The present invention is a system and method of deriving and computing features and indices that predict the likelihood of psychological and neurological adverse events such as suicidal thoughts and/or actions. The method of the present invention further predicts the likelihood of suicidal thoughts and/or actions prior to and or during treatment for psychological disease. To obtain such features and indices, power spectrum and time domain values are derived from biopotential signals acquired from the subject being tested. The system and method identify people who are likely to experience changing, especially worsening, symptoms of psychological and neurological adverse events such as suicidal thoughts or actions and who therefore may be at risk (e.g. suicide).
REFERENCES:
patent: 4407299 (1983-10-01), Culver
patent: 4533346 (1985-08-01), Cosgrove, Jr. et al.
patent: 4736751 (1988-04-01), Gevins et al.
patent: 4862359 (1989-08-01), Trivedi et al.
patent: 4907597 (1990-03-01), Chamoun
patent: 5010891 (1991-04-01), Chamoun
patent: 5083571 (1992-01-01), Prichep
patent: 5119816 (1992-06-01), Gevins
patent: 5230346 (1993-07-01), Leuchter et al.
patent: 5269315 (1993-12-01), Leuchter et al.
patent: 5299569 (1994-04-01), Wernicke et al.
patent: 5309923 (1994-05-01), Leuchter et al.
patent: 5311876 (1994-05-01), Olsen et al.
patent: 5320109 (1994-06-01), Chamoun et al.
patent: 5331970 (1994-07-01), Gevins et al.
patent: 5458117 (1995-10-01), Chamoun et al.
patent: 5568816 (1996-10-01), Gevins et al.
patent: 5846208 (1998-12-01), Pichlmayr et al.
patent: 5871517 (1999-02-01), Abrams et al.
patent: 6024707 (2000-02-01), Scinto et al.
patent: 6066163 (2000-05-01), John
patent: 6205359 (2001-03-01), Boveja
patent: 6263237 (2001-07-01), Rise
patent: 6304775 (2001-10-01), Lasemidis et al.
patent: 6343229 (2002-01-01), Siebler et al.
patent: 6425852 (2002-07-01), Epstein et al.
patent: 6459936 (2002-10-01), Fischell et al.
patent: 6463328 (2002-10-01), John
patent: 6539263 (2003-03-01), Schiff et al.
patent: 6622036 (2003-09-01), Suffin
patent: 7206632 (2007-04-01), King
patent: 7231245 (2007-06-01), Greenwald et al.
patent: 2002/0012312 (2002-01-01), Ogasawara et al.
patent: 2002/0013612 (2002-01-01), Whitehurst
patent: 2002/0013812 (2002-01-01), Krueger et al.
patent: 2003/0023282 (2003-01-01), Barrett et al.
patent: 2003/0135128 (2003-07-01), Suffin et al.
patent: 2003/0181821 (2003-09-01), Greenwald et al.
patent: 2003/0204135 (2003-10-01), Bystritsky
patent: 2005/0043774 (2005-02-01), Devlin et al.
patent: 2005/0216071 (2005-09-01), Devlin et al.
patent: WO 03/057029 (2003-07-01), None
patent: WO 2004/100765 (2004-11-01), None
Brent, David et al., “Early-Onset Mood Disorder”, www.acnp.org/g4/GN40100158/CH154.html, printed Nov. 10, 2008.
Diego, Miguel A. et al., “CES-D Depression Scores Are Correlated With Frontal EEG Alpha Asymmetry”, Depression and Anxiety 13:32-37 (2001).
Graae, Flemming et al., “Abnormality of EEG Alpha Asymmetry in Female Adolescent Suicide Attempters”, Biol. Physchiatry 40:706-713 (1996).
Hunter, Aimee M. et al. “Neurophysiologic Correlates of Side Effects in Normal Subjects Randomized to Venlafaxine or Placebo”, Neurophysopharmacology 1-8 (2004).
Struve, Frederick A., “Electroencephalographic Relationship to Suicidal Behavior: Qualitative Considerations and a Report on a Series of Completed Suicides”, Clin. Electroencephalography, vol. 14 (1): 20-26 (1983).
Struve, Frederick A., “Possible Potentiation of Suicide Risk in Patients with EEG Dysrhythmias Taking Oral Contraceptives: A Speculative Empirical Note”, Clin. Electroencephalography, vol. 16 (2): 88-90 (1985).
Struve, Frederick A., Suide and Life-Threatening Behavior, vol. 16(2), Ch. 3 “Clinical Electroencephalography and a Study of Suicide Behavior”, pp. 51-83 (Summer 1986).
Alkire, Michael T., Quantitative EEG Correlations with brain Glucose Metabolic Rate during Anesthesia in Volunteers, Anesthesiology, 98:323-33 (1998).
Besthorn et al., “Discrimination of Alzheimer's Disease and Normal Aging by EEG Data,” Electroencephalography and Clin. Neurophysiology, 103:241-48 (1997).
Coben et al., “A Longitudinal EEG Study of Mild Senile Dementia of Alzheimer Type: Changes at 1 Year and at 2.5 Years,” Electroencephalogr. Clin. Neurophysiol., 2:101-12 (1985).
Claus et al., “The Diagnostic Value of Electroencephalography in Mild Senile Alzheimer's Disease,” Clin. Neurophysiology, 110:825-32 (1999).
Cook et al., “Prefrontal Changes and Treatment Response Prediction in Depression,” Seminar in Clinical Neuropsychiatry, 6:113-20 (2001).
Diego et al., “CES-D Depression Scores are Correlated with Frontal EEG Alpha Asymmetry,” Depression and Anxiety, 13:32-7 (2001).
Folstein, et al., “Mini-Mental State a Practical Method for Grading the Cognitive State of Patients for the Clinician,” J. Psychiat res., 12:189-98 (1975).
Glass et al., “Bispectral Analysis Measures Sedation and Memory Effects of Propofol, Midazolam, Isoflurane, and Alfentanil in Health Volunteers,” Anesthesiology, 86:836-47 (1997).
Hamilton, M., “A Rating Scale for Depression,” J. Neurol. Neurosurg. Psychiat., 23:56-62 (1960).
Hassainia et al., “Quantitative EEG and Statistical Mapping of Wakefulness and REM Sleep in the Evaluation of Mild to Moderate Alzheimer's Disease,” Eur. Neurol., 37:219-24 (1997).
Holschneider et al., “Loss of High-Frequency Brain Electrical Response to Thipental Administration in Alzheimer's-Type Dementia,” Neurophycopharmacology, 16:26-275 (1997).
Jonkman, EJ., “The Role of the Electroencephalogram in the Diagnosis of Dementia of the Alzheimer Type: an Attempt at Technology Assessment,” Neurophysiol. Clin. 27:211-19 (1997).
Knott, Verner 1., “Quantitative EEG in the Prediction of Antidepressant Response to Imipramine,” J. Affective Disorders, 39: 175-84 (1996).
Knott et al., “Pre-Treatment EEG and Its Relationship to Depression Severity and Paroxetine Treatment Outcome,” Pharmacopsychiatry, 33:302-05 (2000).
Leuchter, A. F., “Regional Differences in Brain Electrical Activity in Dementia: Use of Spectral Power and Spectral Ratio Measures,” Electroencephalography and Clinical Neurophysiology, 87:385-93 (1993).
McKhann et al., “Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease,” Neurology, 34:939-44 (1984).
Neufeld, M.Y., “Effects of a Single Intravenous Dose of Scopolamine on the Quantitative EEG in Alzheimer's Disease Patients and Age-Matched Controls,” Electroencephalography and Clin. Neurophysiology, 91:407-12 (1994).
Pezard, L., “Entropy Maps Characterizer Drug Effects on Brain Dynamics in Alzheimer's Disease,” Neuroscience Letters, 253:5-8, (1998).
Rampil, I., “A Primer for EEG Signal Processing in Anesthesia,” Anesthesiology, 89(4):980-1002 (1998).
Renna, M., “Does Dementia Affect the Bispectral Index?” Amer. Society of Anesthesiologists, p. 1 of 2 (2001).
Jasper, H. H., “The Ten-Twenty Electrode System of the International Federation in Electroencephalography and Clinical Neurology,”• The EEG Journal, 10 (Appendix):371-75 (1958).
Murphy et al., •Stimulation of the Nervous System for the Management of Seizures: CNS Drugs. 17(2):101-15 (2003).
Marqui et al., International Journal of Psychophysiology, 18:49-65 (1994).
Pizzagalli. et al., “Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis”, American Journal of Psychiatry, 158:3, 405-15 (2001).
Struys, M.D., Michel, RUGLOOP Software, Univ. of Gent, department of Anaesthesia, Belgium (1995).
Devlin Philip H.
Greenwald Scott D.
Sigl Jeffrey C.
Mallari Patricia C
Nellcor Puritan Bennett LLC
LandOfFree
System and method for prediction of adverse events during... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for prediction of adverse events during..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for prediction of adverse events during... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2705600